药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Podofilox
Metreleptin
The metabolism of Pazopanib can be increased when combined with Metreleptin.
Podofilox
Zopiclone
The metabolism of Zopiclone can be decreased when combined with Pazopanib.
Podofilox
Tofacitinib
The metabolism of Tofacitinib can be decreased when combined with Pazopanib.
Podofilox
Retapamulin
The metabolism of Retapamulin can be decreased when combined with Pazopanib.
Podofilox
Troleandomycin
The metabolism of Pazopanib can be decreased when combined with Troleandomycin.
Podofilox
Boceprevir
The metabolism of Pazopanib can be decreased when combined with Boceprevir.
Podofilox
Midostaurin
The metabolism of Pazopanib can be decreased when combined with Midostaurin.
Podofilox
Danoprevir
The metabolism of Pazopanib can be decreased when combined with Danoprevir.
Podofilox
Ribociclib
The metabolism of Pazopanib can be decreased when combined with Ribociclib.
Podofilox
Stiripentol
The metabolism of Pazopanib can be decreased when combined with Stiripentol.
Podofilox
Elvitegravir
The metabolism of Pazopanib can be decreased when combined with Elvitegravir.
Podofilox
Ditiocarb
The metabolism of Pazopanib can be decreased when combined with Ditiocarb.
Podofilox
Iloperidone
The metabolism of Iloperidone can be decreased when combined with Pazopanib.
Podofilox
Sodium zirconium cyclosilicate
Sodium zirconium cyclosilicate can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Salvianolic acid A
Salvianolic acid A can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Dexrabeprazole
Dexrabeprazole can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Dexlansoprazole
Dexlansoprazole can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Aluminium phosphate
Aluminium phosphate can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Calcium silicate
Calcium silicate can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Podofilox
Aloglutamol
Aloglutamol can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.